Verastem (VSTM) Preferred Dividend Payments (2011 - 2012)
Verastem's (VSTM) quarterly Preferred Dividend Payments came in at $6000.0 in Q1 2012, up 50.0% year-on-year from $4000.0 in Q2 2011, and down 57.14% quarter-over-quarter from $14000.0 in Q4 2011.
Verastem (VSTM) Preferred Dividend Payments (2011 - 2012) Analysis & Trends
Verastem's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $6000.0 for Q1 2012.
- On a quarterly basis, Preferred Dividend Payments rose 50.0% year-over-year to $6000.0 in Q1 2012; TTM through Dec 2012 was $6000.0, a 81.25% decrease from a year earlier, with the FY2012 full-year figure at $6000.0, down 81.25% from the prior year.
- Preferred Dividend Payments retreated to $6000.0 in Q1 2012 per VSTM's latest filing, from $14000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $14000.0 in Q4 2011 and bottomed at $4000.0 in Q1 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 6,000.00 |
| Dec 31, 2011 | 14,000.00 |
| Sep 30, 2011 | 10,000.00 |
| Jun 30, 2011 | 4,000.00 |
| Mar 31, 2011 | 4,000.00 |